Thromboembolic Disease and Present Oral Contraception

Oral contraceptives and thromboembolic disease.

Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.

OBJECTIVE To assess the risk of cerebral thromboembolism in women using low dose oral contraceptives. DESIGN A retrospective case-control study. SETTING All Danish medical, neurological, neurosurgical, and gynaecological departments. SUBJECTS All 794 women in Denmark aged 15-44 who had suffered a cerebral thromboembolic attack during 1985-9 and 1588 age matched randomly selected controls....

Oral Contraception and Stroke

Background and Purpose A nested case-control analysis of data collected during the prospective Royal College of General Practitioners' Oral Contraception Study was performed to examine the relation between use of oral contraception and risk of stroke. Methods The 253 women who had a first-ever stroke (International Classification of Diseases, eighth revision, codes 4300 to 4389) or amaurosis fu...

Epilepsy and oral contraception.

A controlled cross-over trial in 20 epileptic women, receiving regular anticonvulsant therapy showed that an oral contraceptive with a low oestrogen/ progestogen content had no significant effect on the average frequency of fits compared with identical dummy tablets.

Migraine and Oral Contraception

Between 15% and 17% of Canadian women are afflicted with migraine at some point in their lives.1 Several internal and external factors can modulate the frequency and severity of the condition. In women, variations in the hormonal milieu—from puberty to menopause—have a definite influence in the clinical expression of migraine. Migraine is more likely to be active at the time of menses, and for ...